AMETEK (NYSE: AME) director gets 950-share grant, boosts equity stake

Rhea-AI Filing Summary

AMETEK director Gretchen W. McClain received 950 shares of common stock as a restricted stock award at $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related grant, not an open‑market purchase.

McClain now holds 18,981 shares of common stock directly after this award. She also acquired 52 additional common stock units through dividend reinvestments in the Deferred Compensation Plan, bringing her deferred compensation holdings to 3,199 units. These transactions reflect routine equity compensation and plan reinvestments rather than discretionary trading.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McClain Gretchen W

(Last) (First) (Middle)

172 WHITE PINE CANYON ROAD

(Street)

PARK CITY UTAH 84060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		A(1)		950	A	$212.77	18,981	D
Common Stock/ Deferred Compensation	03/18/2026		J(2)		52	A	$0(2)	3,199	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

2. Represents dividend reinvestments pursuant to the Deferred Compensation Plan.

Remarks:

	/s/ Lynn Carino, attorney-in-fact for Ms. McClain	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AMETEK (AME) director Gretchen McClain report?

AMETEK director Gretchen W. McClain reported receiving 950 shares of common stock as a restricted stock award. The grant was issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan at $212.77 per share, reflecting equity-based director compensation rather than an open-market purchase.

How many AMETEK (AME) shares does Gretchen McClain hold after this Form 4?

After the reported transactions, Gretchen McClain holds 18,981 AMETEK common shares directly. She also has 3,199 common stock units in a Deferred Compensation Plan. These positions include the new 950-share restricted stock award and additional units from recent dividend reinvestments.

Was Gretchen McClain’s AMETEK (AME) Form 4 a market buy or a compensation grant?

The Form 4 reflects a compensation grant, not a market buy. McClain received 950 restricted shares under the 2020 Omnibus Incentive Compensation Plan, categorized as a grant or award acquisition, which is standard director equity compensation instead of an open‑market transaction.

What does the 52-share AMETEK (AME) transaction in the Deferred Compensation Plan represent?

The 52-share transaction represents dividend reinvestments in AMETEK’s Deferred Compensation Plan. These reinvested dividends increased Gretchen McClain’s deferred common stock units to 3,199, categorized as an “other” transaction rather than a traditional buy or sell in the open market.

Does Gretchen McClain’s AMETEK (AME) Form 4 indicate any stock sales?

The Form 4 does not report any stock sales by Gretchen McClain. It shows a 950-share restricted stock grant and 52 additional units from dividend reinvestments in a Deferred Compensation Plan, both of which are non‑sale, compensation-related or administrative equity adjustments.